NRC Health (NRC) Return on equity 2016–2025
NRC Health (NRC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
82.9%FY2025 · since FY2016: 24.8% → 82.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 82.9% | +3.7 pp |
| FY2024 | 79.2% | +16.0 pp |
| FY2023 | 63.3% | +19.1 pp |
| FY2022 | 44.1% | +0.2 pp |
| FY2021 | 43.9% | -14.0 pp |
| FY2020 | 57.9% | -40.6 pp |
| FY2019 | 98.5% | -58.9 pp |
| FY2018 | 157.5% | +132.0 pp |
| FY2017 | 25.5% | +0.7 pp |
| FY2016 | 24.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice